Literature DB >> 13160706

The treatment of leukemia.

J H BURCHENAL.   

Abstract

Entities:  

Keywords:  CHEMOTHERAPY; LEUKEMIA/therapy; RADIOTHERAPY

Mesh:

Year:  1954        PMID: 13160706      PMCID: PMC1804492     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN: 0028-7091


× No keyword cloud information.
  7 in total

1.  Clinical evaluation of a new antimetabolite, 6-mercaptopurine, in the treatment of leukemia and allied diseases.

Authors:  J H BURCHENAL; M L MURPHY; R R ELLISON; M P SYKES; T C TAN; L A LEONE; D A KARNOFSKY; L F CRAVER; H W DARGEON; C P RHOADS
Journal:  Blood       Date:  1953-11       Impact factor: 22.113

2.  Prognosis for survival in the leukemias of childhood; review of the literature and the proposal of a simple method of reporting survival data for these diseases.

Authors:  H TIVEY
Journal:  Pediatrics       Date:  1952-07       Impact factor: 7.124

3.  Antagonists of nucleic acid derivatives. VI. Purines.

Authors:  G B ELION; G H HITCHINGS; H VANDERWERFF
Journal:  J Biol Chem       Date:  1951-10       Impact factor: 5.157

4.  Resistance to corticotropin, cortisone, and folic acid antagonists in leukemia.

Authors:  E M K PILLERS; J H BURCHENAL; L P ELIEL; O H PEARSON
Journal:  J Am Med Assoc       Date:  1952-03-22

5.  Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use.

Authors:  D A KARNOFSKY; J H BURCHENAL; G C ARMISTEAD; C M SOUTHAM; J L BERNSTEIN; L F CRAVER; C P RHOADS
Journal:  AMA Arch Intern Med       Date:  1951-04

6.  Titrated, regularly spaced radioactive phosphorus or spray roentgen therapy of leukemias.

Authors:  E E OSGOOD
Journal:  AMA Arch Intern Med       Date:  1951-03

7.  Present status of ACTH, cortisone, and the antimetabolites in the treatment of leukemia and related diseases.

Authors:  J H BURCHENAL
Journal:  Acta Haematol       Date:  1952-04       Impact factor: 2.195

  7 in total
  1 in total

1.  [Present status of chemotherapy in human neoplastic diseases].

Authors:  J PIRWITZ
Journal:  Klin Wochenschr       Date:  1957-05-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.